The next level in diagnostic power for the clinical lab
The NextSeq 550Dx instrument is FDA regulated and CE-in vitro diagnostic (IVD) marked, enabling clinical laboratories to develop and perform a wide range of applications, from NGS IVD assays using targeted panels, to clinical research applications that include methods from targeted panels to whole genomes.
Flexibility of Dual Operating Modes
Work within a regulated sequencing workflow for developing diagnotic tests and leveraging future NGS IVD tests in the pipeline, while retaining the flexibility to work in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.
Consistency of a Clinical Instrument
The instrument and sequencing reagents are all regulated by the FDA, developed under design control principles, manufactured under Current Good Manufacturing Practices (cGMPs), and verified for consistent assay performance.
Design Your Own NGS Assays for Use on the NextSeq 550Dx System
Paired with the TruSeq Custom Amplicon Kit Dx library preparation kit and the NextSeq 550Dx Reagent Kit, the NextSeq 550Dx is part of an IVD development toolkit that enables clinical labs to design clinical assays with regulated components*.
Workflow
Prep
Benefit from a pipeline of IVD tests in development or develop your own.
Sequence
Automated sequencing generates data in less than 35 hours.
Analyze
The selected analysis initiates automatically and delivers results in a few hours.